Abstract
Regulatory risk communications are an important method for disseminating drug safety information, but their impact varies. Two significant UK risk communications about antipsychotic use in older people with dementia were issued in 2004 and 2009. These varied considerably in their content and dissemination, allowing examination of their differential impact.
Original language | English |
---|---|
Pages (from-to) | e68976 |
Journal | PLoS ONE |
Volume | 8 |
Issue number | 7 |
DOIs | |
Publication status | Published - 17 Jul 2013 |